HomeCompareGMSQF vs JNJ

GMSQF vs JNJ: Dividend Comparison 2026

GMSQF yields 1481.48% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GMSQF wins by $626785561.43M in total portfolio value
10 years
GMSQF
GMSQF
● Live price
1481.48%
Share price
$0.14
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$626785561.46M
Annual income
$553,314,905,198,340.25
Full GMSQF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — GMSQF vs JNJ

📍 GMSQF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGMSQFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GMSQF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GMSQF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GMSQF
Annual income on $10K today (after 15% tax)
$125,925.93/yr
After 10yr DRIP, annual income (after tax)
$470,317,669,418,589.20/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, GMSQF beats the other by $470,317,669,414,603.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GMSQF + JNJ for your $10,000?

GMSQF: 50%JNJ: 50%
100% JNJ50/50100% GMSQF
Portfolio after 10yr
$313392780.74M
Annual income
$276,657,452,601,514.80/yr
Blended yield
88.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GMSQF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GMSQF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGMSQFJNJ
Forward yield1481.48%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$626785561.46M$30.3K
Annual income after 10y$553,314,905,198,340.25$4,689.40
Total dividends collected$621430185.90M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GMSQF vs JNJ ($10,000, DRIP)

YearGMSQF PortfolioGMSQF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$158,848$148,148.15$10,592$272.30+$148.3KGMSQF
2$2,369,319$2,199,351.31$11,289$357.73+$2.36MGMSQF
3$33,193,761$30,658,589.95$12,123$472.89+$33.18MGMSQF
4$436,939,498$401,422,173.47$13,141$629.86+$436.93MGMSQF
5$5,405,881,572$4,938,356,308.99$14,408$846.81+$5405.87MGMSQF
6$62,885,313,260$57,101,019,978.27$16,021$1,151.60+$62885.30MGMSQF
7$688,074,536,789$620,787,251,600.62$18,122$1,588.22+$688074.52MGMSQF
8$7,084,361,831,143$6,348,122,076,778.87$20,930$2,228.20+$7084361.81MGMSQF
9$68,664,164,726,111$61,083,897,566,788.09$24,792$3,191.91+$68664164.70MGMSQF
10$626,785,561,455,279$553,314,905,198,340.25$30,274$4,689.40+$626785561.43MGMSQF

GMSQF vs JNJ: Complete Analysis 2026

GMSQFStock

GameSquare Esports Inc., through its subsidiaries, operates as a gaming and esports company in Canada. The company operates in two segments, Teams, and Agency Services. The Teams segment provides sponsorships, prizes, and players to teams. The Agency Services segment represents esports players and influencers, including Twitch streamers, YouTubers, and gaming personalities, as well as other on-screen talent, such as commentators, analysts, event hosts, and production crew. This segment also provides consulting services to individuals and businesses operating in various roles in the esports industry, including ventures, sponsors, and investors; tournament organizers; game publishers and developers; and producers and broadcasters, as well as advises players, influencers, and other on-screen talent in the esports industry on matters relating to the production of events and campaigns. In addition, this segment offers digital media, as well as gaming and lifestyle marketing agency services. GameSquare Esports Inc. is based in Toronto, Canada.

Full GMSQF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this GMSQF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GMSQF vs SCHDGMSQF vs JEPIGMSQF vs OGMSQF vs KOGMSQF vs MAINGMSQF vs ABBVGMSQF vs MRKGMSQF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.